
    
      The objectives of this study are to evaluate the safety and efficacy of corneal collagen
      cross-linking performed with VibeX (riboflavin ophthalmic solution) and the KXL System as
      compared to placebo in impeding the progression of, and/or reducing, maximum corneal
      curvature.
    
  